Enhancing NIH Research on Autoimmune Disease (2022) / Chapter Skim
Currently Skimming:
Pages 499-508
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 499... ...
7 ‘‘(d) REPORT. -- Not later than October 1, 2001, the 8 Comptroller General shall prepare and submit to the ap 9 propriate committees of Congress a report concerning the 10 effectiveness of the Office in promoting advancements in 11 research, diagnosis, treatment, and prevention related to 12 autoimmune diseases.
|
From page 501... ...
They are described below, along with the methods used to describe different aspects of the research portfolio (spending on autoimmune disease research by NIH and Institute and Centers (ICs) ; spending on autoimmune disease research by research activity; spending on autoimmune disease research by disease; IC collaborations; clinical trials, publications, and patents associated with autoimmune disease research grants; and an analysis of study sections reviewing autoimmune disease grants)
|
From page 502... ...
Spending categories can also be added at the request of the Director of NIH or an IC. As of June 2021, there are 299 research/disease areas in RCDC, including the Autoimmune Disease spending category of interest to the committee.
|
From page 503... ...
Autoimmune Disease Spending Methodology The committee used the NIH RePORTER database to evaluate funding and other aspects of the NIH autoimmune disease research portfolio. The RePORTER database allows users to query or search by the spending categories specified by RCDC (presented as "NIH Spending Category" in the RePORTER advanced projects search)
|
From page 504... ...
Grants can be counted in more than one disease category. Grants that were not associated with any specific disease categories were labeled as "other autoimmune disease." This methodology applies to all tables and figures that provide analyses by the committee's autoimmune diseases of interest.
|
From page 505... ...
Due to the different purposes of the data systems, neither system provides a complete estimate of the total cost of autoimmune disease research funding by IC. The committee created a new variable, Combined Total Cost of Funded Autoimmune Research to address this issue and added it to the CRD.
|
From page 506... ...
Additionally, RePORTER separates Total Cost for projects and Total Cost for subprojects, making it challenging to determine the total amount of dollars any one IC spent on autoimmune disease research. A new variable, "Combined Total Cost of Autoimmune Disease Research," was created to reflect consolidated funding for stand-alone projects and subprojects in one variable; it was added to the CRD.
|
From page 507... ...
This methodology was used in the analyses associated with Table 6-8. Study Section Analysis The committee used the online CSR study section tool available at https://public.csr.nih.gov/StudySections.10 The committee entered the name of each of the select autoimmune diseases of committee interest into the study section search field to identify the names of its associated chartered study sections.
|
From page 508... ...
was then tallied. The committee used the RePORTER Matchmaker search tool available at https://reporter.nih.gov/matchmaker.11 The committee entered the name of each of the select autoimmune diseases of committee interest into the field to yield the number of projects associated with that disease.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.